Search All News
The three scientists honored by the 2019 Horwitz Prize played key roles in identifying and deciphering the PI3K pathway, which has led to new treatments for several types of cancer.
By learning how contagious cancer spreads among shellfish, scientists hope to better understand how cancer metastasizes in people.
Researchers at Columbia are tackling cancer disparities in northern Manhattan and surrounding areas through the National Cancer Institute’s network of community-based research programs.
Columbia oncologists are bringing their latest techniques in precision medicine to veterans with advanced prostate cancer.
- December 19, 2018
In a phase three clinical trial, sorafenib stopped progression of desmoid tumors for two years in 80 percent of patients who completed treatment.
- December 10, 2018
Anil K. Rustgi, MD, an expert in gastrointestinal tumors, will join Columbia University Irving Medical Center and NewYork-Presbyterian as director of the Herbert Irving Comprehensive Cancer Center.
- December 10, 2018
A new study suggests that a type of brain tumor in patients with neurofibromatosis type 1 could be treated with immunotherapy, which has so far proved ineffective in treating most brain cancers.
- October 31, 2018
A new study found that women with cervical cancer who had a radical hysterectomy with minimally invasive surgery had a significantly higher risk of death than those who had open surgery.
- October 12, 2018
For the second year, Velocity, Columbia's Ride to End Cancer raised more than $1 million for cancer care and research.
- September 28, 2018
Sarah Urke and Barbara Trencher, Columbia physical therapists and Velocity participants, developed an exercise program for cancer patients.
- September 20, 2018
Leaders in prostate cancer research and care will convene Sept. 22 for the inaugural NYC Prostate Cancer Summit, a patient-focused event co-hosted by CUIMC and NewYork-Presbyterian.